Bird flu cases in the US and Australia spark a surge in vaccine stocks. The discoveries, including a mild case in Michigan and Australia's first, raise concerns about potential human-to-human transmission and the need for further research.

Following two reports of human bird flu infections—one in the US and the other in Australia—shares of vaccine makers saw a sharp rise on Wednesday. The growing possibility of human-to-human transmission, which is still unknown, is being closely watched...